AB254450
MW 513.7 Da, Purity >98%. Potent and selective CCR5 antagonist. Blocks binding of MIP-1 alpha (IC50 = 3.3 nM), MIP-1 beta (IC50= 7.2 nM) and RANTES (IC50 = 5.2 nM) to CCR5 in radioligand binding competition assays. Potent anti-HIV activity. Blocks HIV-1 gp120 binding to CCR5 (IC50 = 6.4 nM) preventing cell-cell fusion. Induces macrophage repolarization with anti-tumor effects.
1 Images
- Chemical Structure
Supplier Data
Chemical Structure - Maraviroc, CCR5 Antagonist (AB254450)
2D chemical structure image of ab254450, Maraviroc, CCR5 Antagonist
Product details
Solutions in DMSO may be stored at -20°C for up to 3 months.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
iScience 26:106059 PubMed36824275
2023
BATF2 promotes HSC myeloid differentiation by amplifying IFN response mediators during chronic infection.
Applications
Unspecified application
Species
Unspecified reactive species
Duy T Le,Marcus A Florez,Pawel Kus,Brandon T Tran,Bailee Kain,Yingmin Zhu,Kurt Christensen,Antrix Jain,Anna Malovannaya,Katherine Y King
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com